• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO KG M.BLUE PLUS SYS W/PED.CONTROL RESERVOIR; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO KG M.BLUE PLUS SYS W/PED.CONTROL RESERVOIR; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FX819T
Medical Device Problem Codes Mechanical Problem (1384); Infusion or Flow Problem (2964)
Health Effect - Clinical Code Hydrocephalus (3272)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Additional information /investigation will be submitted in a supplemental report.
 
Event or Problem Description
It was reported that a m.Blue plus (# (b)(4)) was implanted during a procedure performed on an unspecified date.According to the complainant, the shunt system was believed to be operating in underdrainage and difficult to adjust.The patient underwent a revision procedure.No patient complications were reported as a result of the revision procedure.Age: (b)(6), height: unknown, weight: (b)(6) kg, gender: female.
 
Additional Manufacturer Narrative
Investigation: visual inspection: dried deposit in the ped.Controlreservoir were observed through the visual inspection.No significant deformations or damage were detected.Permeability test: a permeability test has indicated that all components have blockages.Computer controlled test: not applicable.Adjustment test: the m.Blue was tested and is adjustable to all specified pressures.The progav® 2.0 was tested and is not adjustable.Klick force and brake function test m.Blue: the brake functionality test has shown that the brake function is fully operational and the braking force is within the given tolerances.Progav 2.0: the brake functionality test has shown that the brake function is operational, however the braking force cannot be measured due to the non-adjustability of the valve.Internal inspection : after dismantling of the valves, deposits were found in both valves results: it should be noted that the product was received dry (i.E.Not submersed in liquid as recommended).The investigation of dry items is not significant due to the affect dry deposits of liquor and blood can have on product performance.In spite of this, we have investigated the valve to the best of our abilities.Based on our test results, we can determine a blockage of both valves as well as a non-adjustability on the progav 2.0 valve at the time of our investigation.We are assuming that the deposits detected within the valves have caused the functional impairment.Deposits caused by natural substances in the cerebrospinal fluid, such as protein, blood or tissue particles, are among the known and unavoidable risks and side effects of hydrocephalus therapy.Small amounts of non-visible deposits/proteins might compromise the integrity of the valve.We can exclude a defect at the time of release.The shunt system met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.No further regulatory actions are required from our point of view.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
M.BLUE PLUS SYS W/PED.CONTROL RESERVOIR
Common Device Name
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM  14469
Manufacturer (Section G)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM   14469
Manufacturer Contact
joerg knebel
ulanenweg 2
potsdam, 14469
GM   14469
MDR Report Key13176959
Report Number3004721439-2021-00356
Device Sequence Number4561607
Product Code JXG
UDI-Device Identifier04041906504526
UDI-Public4041906504526
Combination Product (Y/N)N
Initial Reporter CountrySZ
PMA/510(K) Number
K192266
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,User Facility,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 01/11/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/09/2025
Device Model NumberFX819T
Device Catalogue NumberFX819T
Device Lot Number20049313
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/20/2021
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/14/2021
Supplement Date Received by Manufacturer01/06/2022
Initial Report FDA Received Date01/06/2022
Supplement Report FDA Received Date01/11/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/14/2020
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age6 MO
Patient SexFemale
Patient Weight6 KG
-
-